Keyphrases
Adenocarcinoma
50%
Anticancer Therapeutics
8%
Cancer Therapeutic Strategy
8%
Clear Cell Adenocarcinoma of the Ovary
8%
Everolimus
25%
Expression Alteration
8%
Growth Factor Pathway
100%
Hypoxia-inducible factor-1α (HIF-1α)
100%
Hypoxic State
8%
Immunohistochemical Expression
8%
Malignant Tumor
16%
Mammalian Target of Rapamycin (mTOR)
100%
Mammalian Target of Rapamycin Pathway
8%
No Significant Difference
8%
Ovarian Clear Cell Adenocarcinoma
100%
Overexpression
8%
Rapamycin
8%
Resection Specimen
8%
Serous Adenocarcinoma
33%
Serous Cell
8%
Targeted Therapy
8%
Therapeutic Strategies
100%
Tumor
8%
Tumor Cell Proliferation
8%
Tumor Suppression
8%
Vascular Endothelial Growth Factor
100%
Western Blot
8%
Xenograft Model
8%
Medicine and Dentistry
Adenocarcinoma
100%
Cancer Inhibition
8%
Cell Line
8%
Downregulation
8%
Everolimus
25%
Hypoxia Inducible Factor 1
100%
Malignant Neoplasm
25%
Mammalian Target of Rapamycin
33%
Mechanistic Target of Rapamycin
100%
Neoplasm
8%
Rapamycin
8%
Targeted Therapy
8%
Tumor Progression
8%
Vasculotropin
100%
Western Blotting
8%
Xenograft
8%
Pharmacology, Toxicology and Pharmaceutical Science
Adenocarcinoma
100%
Cancer Inhibition
8%
Everolimus
25%
Hypoxia Inducible Factor 1
100%
Malignant Neoplasm
25%
Mammalian Target of Rapamycin
100%
Neoplasm
8%
Rapamycin
8%
Tumor Growth
8%
Vasculotropin
100%
Western Blot
8%